Both in Pharmaceuticals
Merck & Co. vs Abbott Laboratories
Over the past year MRK returned +75.5% and ABT returned −11.3%; their daily moves had a correlation of 0.32.
MRK +75.5% ABT −11.3%Growth of $1, one year, split-adjusted
| Metric | MRK | ABT |
|---|---|---|
| Price | $144.74 | $109.87 |
| Market cap | $357.09B | $190.12B |
| Today | −2.44% | −0.26% |
| 1 month | +3.7% | +9.8% |
| 6 months | +27.9% | +26.0% |
| Year to date | +37.5% | −12.3% |
| 1 year | +68.3% | −11.1% |
| Revenue growth (YoY) | +5.1% | +13.0% |
| Gross margin | 73.5% | 57.7% |
| Net margin | −8.0% | 7.4% |
| P/E (TTM) | 112.5× | 35.0× |
| Price / sales | 5.4× | 4.1× |
| Net cash | -$46.77B | -$27.00B |
| Dividend yield | 2.35% | 2.29% |
| Volatility (60d) | 36.3% | 22.5% |
| Short % of float | 1.1% | 1.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).